Stockholm – November 3, 2025 – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that a collaborative study within the Eurostars ...
Insulet launches campaign inspired by the International Diabetes Federation’s focus on diabetes, well-being, and the workplace“The Day Diabetes Showed Up to Work” campaign recognizes the unique needs ...
November 2025University of Huddersfield Pharmacist Dr Muhammad Usman Ghori has been honoured at the Science and Technology Premier Awards 2025 for his research to bring clean, affordable drinking ...
Lord Vallance, Minister for Science, Innovation, Research and Nuclear opens new facility which will support the acceleration of UK engineering biology innovationLondon, 3 November 2025 - The National ...
Company unveils patented technology designed to help maintain healthy blood flow during vascular proceduresBacked by Sofinnova MD Start and led by experienced medtech entrepreneurs and ...
Expert consensus predicts integration of CTC testing into routine clinical practice within 5 years 2. CTCs provide distinct and impactful information that is not captured by circulating tumour DNA ...
KYGEVVI® (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom ...
PALO ALTO, CA / ACCESS Newswire / November 4, 2025 / Bioz, Inc., the leader in turning scientific literature into actionable product validation, is proud to announce its collaboration with ...
MIAMI, FL / ACCESS Newswire / November 4, 2025 / NAYA Therapeutics, a clinical-stage biopharmaceutical company dedicated to pioneering the next generation of cancer therapies through the development ...
This acceptance marks the fifth major medical conference this year to feature bexmarilimab in an oral session, reinforcing the drug's unique mechanism in hematologic malignancies and potential to ...
VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, ...
CNX Therapeutics acquires the global Sativex business from Jazz Pharmaceuticals to bolster its CNS specialty medicines platform while Jazz rebalances its portfolio toward core areas.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback